Inactive Instrument
Company American Renal Associates Holdings, Inc.
Stocks
ARA
US0292271055
Healthcare Facilities & Services
Business description: American Renal Associates Holdings, Inc.

Sales by Activity: American Renal Associates Holdings, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
The Ownership and Operation of Dialysis Clinics | 823M |
Geographical breakdown of sales: American Renal Associates Holdings, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
United States | 823M |
Executive Committee: American Renal Associates Holdings, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
David Doerr
CEO | Chief Executive Officer | 56 | 01/02/2025 |
Syed Kamal
PSD | President | 73 | 01/01/1999 |
George Attmore
DFI | Director of Finance/CFO | - | - |
Geoffrey Walker
CTO | Chief Tech/Sci/R&D Officer | - | - |
Steve Duke
CTO | Chief Tech/Sci/R&D Officer | - | - |
Company details: American Renal Associates Holdings, Inc.
American Renal Associates Holdings, Inc.
500 Cummings Center
01915, Beverly
+978 922 3080
http://www.innovativerenal.com
Other Healthcare Facilities & Services
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.47% | +3.95% | +31.28% | +47.31% | 124B | ||
| -1.03% | -3.07% | -1.60% | +44.23% | 87.68B | ||
| -1.07% | -3.55% | -6.26% | +49.97% | 28.56B | ||
| -0.94% | -2.32% | +31.66% | +81.69% | 26.17B | ||
| -0.26% | -4.48% | -6.00% | -5.81% | 21.46B | ||
| +0.59% | -0.66% | +37.67% | +236.79% | 21.34B | ||
| -0.70% | +4.77% | -4.89% | +27.59% | 15.8B | ||
| +1.61% | -1.75% | -5.97% | -12.02% | 12.08B | ||
| +1.28% | +1.83% | +35.73% | +78.65% | 11.73B | ||
| Average | -0.11% | -0.62% | +12.40% | +60.93% | 38.73B | |
| Weighted average by Cap. | -0.50% | +0.06% | +15.28% | +55.77% |

















